While Surprised John Sellers and Double Eagle Declined to Take the Helm of Fermi, Neugebauer Reiterates His Call for Board to Find Someone of that Caliber with a Team Who Can Replace the Nine ...

On X, I often come across some version of a stock performance chart showing how Airbnb has performed since its IPO which has ...

Alerts Channel https://t.me/PKScreener > You wil receive all the major alerts on this telegram channel. These alerts are sent for all major strategy scans daily ...

Suzanne is a content marketer, writer, and fact-checker. She holds a Bachelor of Science in Finance degree from Bridgewater State University and helps develop content strategies. Getty Images An IPO, ...

Highlights:First known metallurgical testing on W2 mineralization completed at SGS LakefieldCopper recoveries ranged from 97% at 8.4% Cu grade to 92% at 28% Cu gradePalladium and gold upgraded by 21X ...

SpaceX IPO analysis: valuation at ~25x 2027 sales, AI revenue upside and Starship catalyst. Click for this look at SPCX stock and see if there is opportunity there.

Hot PPI, S&P 500 technical top signals, SpaceX IPO liquidity drain and AI dilution (SMCI, Oracle), oil, gold, Bitcoin setups ...

Researchers and executives at big AI labs like OpenAI, Anthropic, and Google talk about AI-generated code a lot. Tools like Anthropic’s Claude Code, OpenAI’s Codex, and Google’s AlphaCode 2 have ...

Add Decrypt as your preferred source to see more of our stories on Google. Frontier AI models are increasingly being used to identify software vulnerabilities. Claude Mythos, Claude Opus, GPT-5.5, and ...

Anthropic is the latest artificial intelligence unicorn to seek an IPO, following SpaceX and Cerebras. Anthropic's most recent funding round valued it at $965 billion. Hot tech IPOs from recent years ...

Tesla’s latest Cybertruck recall sounds alarming, but the actual scope appears relatively limited. Investors remain far more focused on Tesla’s long-term opportunities in AI, robotics, and autonomy.

After years of suffering from a bear market and more than 14 months of geopolitical turmoil shaking the macroenvironment, biotech appears to be moving on. Emboldened by Kailera Therapeutics’ ...